Literature DB >> 2307455

Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population.

H J Menzel1, G Sigurdsson, E Boerwinkle, S Schrangl-Will, H Dieplinger, G Utermann.   

Abstract

Human apolipoprotein A-IV (apo A-IV) exhibits a genetic polymorphism with two common alleles, A-IV1 and A-IV2, in Caucasian populations. We have investigated this polymorphism in the Icelandic population. The frequencies of the two alleles are significantly different from middel European populations with a higher frequency of the A-IV2 allele (0.117 versus 0.077) occurring in Iceland. The alleles at the apo A-IV locus have significant effects on plasma high density lipoprotein cholesterol (HDL-C) and triglyceride levels. The average effect of the A-IV2 allele is to raise HDL-C by 4.9 mg/dl and to lower triglyceride levels by 19.4 mg/dl. We estimate that the genetic variability at the apo A-IV gene locus accounts for 3.1% of the total variability of HDL-C and for 2.8% of the total variability of triglycerides in the population from Iceland. This confirms and extends our previous observations on apo A-IV allele effects in Tyroleans in an independent population.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307455     DOI: 10.1007/bf00196231

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  14 in total

1.  Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes.

Authors:  E Dvorin; N L Gorder; D M Benson; A M Gotto
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

2.  Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism.

Authors:  E Boerwinkle; G Utermann
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

3.  Lipids and diet in relation to cardiovascular disease in Iceland.

Authors:  G Sigurdsson
Journal:  Br J Clin Pract Suppl       Date:  1987-12

4.  Quantification of human apolipoprotein A-IV by "sandwich"-type enzyme-linked immunosorbent assay.

Authors:  M Rosseneu; G Michiels; W De Keersgieter; J Bury; J P De Slypere; H Dieplinger; G Utermann
Journal:  Clin Chem       Date:  1988-04       Impact factor: 8.327

5.  Human intestinal lipoproteins. Studies in chyluric subjects.

Authors:  P H Green; R M Glickman; C D Saudek; C B Blum; A R Tall
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

6.  Apolipoprotein A-IV polymorphism in man.

Authors:  H J Menzel; P M Kövary; G Assmann
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

7.  Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels.

Authors:  H J Menzel; E Boerwinkle; S Schrangl-Will; G Utermann
Journal:  Hum Genet       Date:  1988-08       Impact factor: 4.132

8.  One-step screening method for the polymorphism of apolipoproteins A-I, A-II, and A-IV.

Authors:  H J Menzel; R G Kladetzky; G Assmann
Journal:  J Lipid Res       Date:  1982-08       Impact factor: 5.922

9.  Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes.

Authors:  S K Karathanasis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

10.  Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV.

Authors:  A Steinmetz; G Utermann
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

View more
  2 in total

1.  Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein.

Authors:  D J Rader; J Schäfer; P Lohse; B Verges; M Kindt; L A Zech; A Steinmetz; H B Brewer
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

2.  Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population.

Authors:  A von Eckardstein; H Funke; M Schulte; M Erren; H Schulte; G Assmann
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.